Gabexate or Somatostatin Administration before Endoscopic Retrograde Cholangiopancreatography in Patients at Risk for Post-Intervention Pancreatitis: A Multicenter, Placebo-Controlled Randomized Clinical Trial

(Journal Article): Gabexate or Somatostatin Administration before Endoscopic Retrograde Cholangiopancreatography in Patients at Risk for Post-Intervention Pancreatitis: A Multicenter, Placebo-Controlled Randomized Clinical Trial

Clemente R, Andriulli A. On behalf of the Italian Group for the Prevention of Acute Pancreatitis (Casa Sollievo della Sofferenza IRCCS Divisione di Gastroenterologia. San Giovanni Rotondo, FG, Italy)

IN: JOP. J Pancreas (Online) 2001; 02(5 Suppl.):351

Fulltext: HTML PDF

TYPE OF PUBLICATION: Conference Abstract

Respond on this Journal Article!
Hint: Your Response should directly apply to Gabexate or Somatostatin Administration before Endoscopic Retrograde Cholangiopancreatography in Patients at Risk for Post-Intervention Pancreatitis: A Multicenter, Placebo-Controlled Randomized Clinical Trial. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is 2001.